<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[15, 16] doxorubicin<br>[17, 21] pegylated liposomal doxorubicin:<br>[48, 52] doxorubicin (DOX)<br>[54, 57] pegylated liposomal formulation<br></td>
<td width=33%>
[15, 21] doxorubicin or pegylated liposomal doxorubicin:<br>[48, 60] doxorubicin (DOX) or a pegylated liposomal formulation (PLD)<br>[84, 85] DOX<br>[94, 95] PLD<br></td>
<td width=33%>
[9, 10] chemotherapy<br>[14, 21] with doxorubicin or pegylated liposomal doxorubicin:<br>[46, 60] chemotherapy with doxorubicin (DOX) or a pegylated liposomal formulation (PLD)<br>[84, 85] DOX<br>[93, 95] or PLD<br>[254, 257] DOX versus PLD<br></td>
</tr>
